Emerging Pathways in COPD: Targeting Inflammation for A Tailored Treatment Approach - Episode 9

Emerging Treatment Approaches in COPD

Published on: 
, ,

The panel discusses emerging treatment approaches in COPD and reviews the study design and topline results from the BOREAS trial investigating dupilumab.

  1. Can you discuss the emerging treatment approaches in COPD?
    1. The Interleukin-4/Interleukin-13 Receptor
    2. IL-33 Signaling
    3. ST-2 (IL-33R)
  2. We have recently received data form the BOREAS trial on dupilumab in COPD. Can you discuss the design and topline results? Bhatt et al 2023
    1. Phase 3 NOTUS study?